サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1402884

脳腫瘍診断市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年

Brain Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 180 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脳腫瘍診断市場：世界の業界分析、規模、シェア、成長、動向、予測、2023～2031年
出版日: 2023年11月13日
発行: Transparency Market Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

脳腫瘍診断市場- レポートの範囲

世界の脳腫瘍診断市場に関するTMRのレポートは、過去と現在の成長動向、および2023年から2031年の予測期間中に市場の指標の貴重な洞察を得る機会を研究しています。このレポートは、2023年を基準年、2031年を予測年とみなし、2017年から2031年の期間の世界の脳腫瘍診断の収益を提供します。このレポートは、2023年から2031年までの世界の脳腫瘍診断市場の複合年間成長率（CAGR %）も提供します。

このレポートは広範な調査を経て作成されました。1次調査では、調査活動の大部分が行われ、アナリストが主要なオピニオンリーダー、業界リーダー、オピニオンメーカーにインタビューを実施しました。2次調査には、脳腫瘍診断市場を理解するために、主要企業の製品文献、年次報告書、プレスリリース、および関連文書の参照が含まれます。

市場スナップショット
2023年の市場価値 15億米ドル
2031年の市場価値 25億米ドル
CAGR 5.9%

このレポートは、世界の脳腫瘍診断市場の競合情勢を詳しく調査しています。世界の脳腫瘍診断市場で活動する主要企業が特定され、それぞれの企業がさまざまな属性の観点からプロファイルされています。会社概要、財務状況、最近の動向、 SWOTは、このレポートで紹介されている世界の脳腫瘍診断市場のプレーヤーの属性です。

目次

第1章 序文

第2章 前提条件と調査手法

第3章 エグゼクティブサマリー：世界市場

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界市場の分析と予測、2023～2031年

第5章 重要な洞察

  • 脳腫瘍の疫学
  • 脳腫瘍の画像診断および治療における現在の動向
  • がん診断における技術の進歩
  • COVID-19感染症の影響分析

第6章 世界市場の分析と予測：診断手法別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：診断手法別、2023-2031
    • イメージング技術
      • 磁気共鳴画像法（MRI）
      • コンピュータ断層撮影（CT）スキャン
      • PETスキャンまたはPET-CTスキャン
      • （SPECT）スキャン
    • 組織サンプリング/生検
    • 分子診断
    • その他
  • 市場魅力度分析：診断手法別

第7章 世界市場の分析と予測：脳腫瘍の種類別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：脳腫瘍の種類別、2023-2031
    • 神経膠腫
    • 髄膜腫
    • 下垂体腫瘍
    • その他
  • 市場魅力度分析：脳腫瘍の種類別

第8章 世界市場の分析と予測：エンドユーザー別

  • イントロダクションと定義
  • 主な調査結果/発展
  • 市場金額予測：エンドユーザー別、2023-2031
    • 病院
    • 診断研究所
    • がん病院/センター
  • 市場魅力度分析：エンドユーザー別

第9章 世界市場の分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場魅力度分析：地域別

第10章 北米市場の分析と予測

第11章 欧州市場の分析と予測

第12章 アジア太平洋市場の分析と予測

第13章 ラテンアメリカ市場の分析と予測

第14章 中東・アフリカ市場の分析と予測

第15章 競合情勢

  • 市場プレーヤー-競合マトリックス（企業の階層および規模別）
  • 企業別市場シェア分析（2021）
  • 企業プロファイル
    • GE Healthcare
    • Siemens Healthineers
    • Philips Healthcare
    • Thermo Fisher Scientific
    • Roche Diagnostics
    • Abbott Laboratories
    • Illumina, Inc.
    • Hologic, Inc.
    • Agilent Technologies
    • Bio-Rad Laboratories
図表

List of Tables

  • Table 01: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 02: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 03: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 04: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 05: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 06: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 07: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 08: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 09: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 10: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 11: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 12: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 13: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 14: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 15: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 16: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 17: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 18: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 19: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 20: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 21: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Diagnostic Technique, 2023-2031
  • Table 22: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Brain Cancer Type, 2023-2031
  • Table 23: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 24: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

List of Figures

  • Figure 01: Global Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 02: Global Brain Cancer Diagnostics Market Value Share, by Diagnostic Technique 2023
  • Figure 03: Global Brain Cancer Diagnostics Market Value Share, by Brain Cancer Type 2023
  • Figure 04: Global Brain Cancer Diagnostics Market Value Share, by End-user 2023
  • Figure 05: Global Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 06: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Imaging Techniques 2023-2031
  • Figure 07: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Tissue Sampling/Biopsy 2023-2031
  • Figure 08: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Molecular Diagnostics 2023-2031
  • Figure 09: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Others 2023-2031
  • Figure 10: Global Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 11: Global Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 12: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Gliomas 2023-2031
  • Figure 13: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Meningiomas 2023-2031
  • Figure 14: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Pituitary Tumors 2023-2031
  • Figure 15: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Others 2023-2031
  • Figure 16: Global Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 17: Global Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 18: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Hospitals 2023-2031
  • Figure 19: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Diagnostic Laboratories 2023-2031
  • Figure 20: Global Brain Cancer Diagnostics Market Revenue (US$ Mn), by Cancer Hospitals/Centers 2017-2032
  • Figure 21: Global Brain Cancer Diagnostics Market Value Share Analysis, by Region 2023 and 2031
  • Figure 22: Global Brain Cancer Diagnostics Market Attractiveness Analysis, by Region 2023-2031
  • Figure 23: North America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 24: North America Brain Cancer Diagnostics Market Value Share Analysis, by Country 2023 and 2031
  • Figure 25: North America Brain Cancer Diagnostics Market Attractiveness Analysis, by Country 2023-2031
  • Figure 26: North America Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 27: North America Brain Cancer Diagnostics Market Attractiveness Analysis, by Diagnostic Technique 2023-2031
  • Figure 28: North America Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 29: North America Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 30: North America Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 31: North America Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 32: Europe Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 33: Europe Brain Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 34: Europe Brain Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 35: Europe Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 36: Europe Brain Cancer Diagnostics Market Attractiveness Analysis, by Diagnostic Technique 2023-2031
  • Figure 37: Europe Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 38: Europe Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 39: Europe Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 40: Europe Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 41: Asia Pacific Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 42: Asia Pacific Brain Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 43: Asia Pacific Brain Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 44: Asia Pacific Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 45: Asia Pacific Brain Cancer Diagnostics Market Attractiveness Analysis, by Diagnostic Technique 2023-2031
  • Figure 46: Asia Pacific Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 47: Asia Pacific Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 48: Asia Pacific Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 49: Asia Pacific Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 50: Latin America Brain Cancer Diagnostics Market Value (US$ Mn) Forecast 2023-2031
  • Figure 51: Latin America Brain Cancer Diagnostics Market Value Share Analysis, by Country/Sub-region, 2023 and 2031
  • Figure 52: Latin America Brain Cancer Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 53: Latin America Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 54: Latin America Brain Cancer Diagnostics Market Attractiveness Analysis, by Diagnostic Technique 2023-2031
  • Figure 55: Latin America Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 56: Latin America Brain Cancer Diagnostics Market Attractiveness Analysis, by Brain Cancer Type 2023-2031
  • Figure 57: Latin America Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 58: Latin America Brain Cancer Diagnostics Market Attractiveness Analysis, by End-user 2023-2031
  • Figure 59: Middle East & Africa Brain Cancer Diagnostics Market Value (US$ Mn) 2023-2031
  • Figure 60: Middle East & Africa Brain Cancer Diagnostics Market Value Share Analysis, by Country 2023 and 2031
  • Figure 61: Middle East & Africa Brain Cancer Diagnostics Market Attractiveness , by Country 2023-2031
  • Figure 62: Middle East & Africa Brain Cancer Diagnostics Market Value Share Analysis, by Diagnostic Technique 2023 and 2031
  • Figure 63: Middle East & Africa Brain Cancer Diagnostics Market Attractiveness , by Diagnostic Technique 2023-2031
  • Figure 64: Middle East & Africa Brain Cancer Diagnostics Market Value Share Analysis, by Brain Cancer Type 2023 and 2031
  • Figure 65: Middle East & Africa Brain Cancer Diagnostics Market Attractiveness , by Brain Cancer Type 2023-2031
  • Figure 66: Middle East & Africa Brain Cancer Diagnostics Market Value Share Analysis, by End-user 2023 and 2031
  • Figure 67: Middle East & Africa Brain Cancer Diagnostics Market Attractiveness, by End-user 2023-2031
目次
Product Code: TMRGL85859

Brain Cancer Diagnostics Market - Scope of Report

TMR's report on the global brain cancer diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global brain cancer diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global brain cancer diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the brain cancer diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.5 Bn
Market Value in 2031US$ 2.5 Bn
CAGR5.9%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global brain cancer diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global brain cancer diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global brain cancer diagnostics market.

The report delves into the competitive landscape of the global brain cancer diagnostics market. Key players operating in the global brain cancer diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global brain cancer diagnostics market profiled in this report.

Key Questions Answered in Global brain cancer diagnostics Market Report:

  • What is the sales/revenue generated by brain cancer diagnostics across all regions during the forecast period?
  • What are the opportunities in the global brain cancer diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Brain Cancer Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global brain cancer diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global brain cancer diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global brain cancer diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Brain Cancer Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Brain Cancer Diagnostics Market Analysis and Forecasts, 2023-2031

5. Key Insights

  • 5.1. Brain Tumor Epidemiology
  • 5.2. Current Trends in Diagnostic and Therapeutic Imaging of Brain Tumors
  • 5.3. Technological advancements in cancer diagnostics
  • 5.4. COVID-19 Impact Analysis

6. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Diagnostic Technique

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 6.3.1. Imaging Techniques
      • 6.3.1.1. Magnetic Resonance Imaging (MRI)
      • 6.3.1.2. Computed Tomography (CT) Scan
      • 6.3.1.3. PET Scan or PET-CT Scan
      • 6.3.1.4. (SPECT) Scan
    • 6.3.2. Tissue Sampling/Biopsy
    • 6.3.3. Molecular Diagnostics
    • 6.3.4. Others
  • 6.4. Market Attractiveness Analysis, by Diagnostic Technique

7. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Brain Cancer Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 7.3.1. Gliomas
    • 7.3.2. Meningiomas
    • 7.3.3. Pituitary Tumors
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Brain Cancer Type

8. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2023-2031
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Cancer Hospitals/Centers
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Brain Cancer Diagnostics Market Analysis and Forecasts, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Brain Cancer Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 10.2.1. Imaging Techniques
      • 10.2.1.1. Magnetic Resonance Imaging (MRI)
      • 10.2.1.2. Computed Tomography (CT) Scan
      • 10.2.1.3. PET Scan or PET-CT Scan
      • 10.2.1.4. (SPECT) Scan
    • 10.2.2. Tissue Sampling/Biopsy
    • 10.2.3. Molecular Diagnostics
    • 10.2.4. Others
  • 10.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 10.3.1. Gliomas
    • 10.3.2. Meningiomas
    • 10.3.3. Pituitary Tumors
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2023-2031
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Laboratories
    • 10.4.3. Cancer Hospitals/Centers
  • 10.5. Market Value Forecast, by Country, 2023-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Diagnostic Technique
    • 10.6.2. By Brain Cancer Type
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Brain Cancer Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 11.2.1. Imaging Techniques
      • 11.2.1.1. Magnetic Resonance Imaging (MRI)
      • 11.2.1.2. Computed Tomography (CT) Scan
      • 11.2.1.3. PET Scan or PET-CT Scan
      • 11.2.1.4. (SPECT) Scan
    • 11.2.2. Tissue Sampling/Biopsy
    • 11.2.3. Molecular Diagnostics
    • 11.2.4. Others
  • 11.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 11.3.1. Gliomas
    • 11.3.2. Meningiomas
    • 11.3.3. Pituitary Tumors
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2023-2031
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostic Laboratories
    • 11.4.3. Cancer Hospitals/Centers
  • 11.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Diagnostic Technique
    • 11.6.2. By Brain Cancer Type
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Brain Cancer Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 12.2.1. Imaging Techniques
      • 12.2.1.1. Magnetic Resonance Imaging (MRI)
      • 12.2.1.2. Computed Tomography (CT) Scan
      • 12.2.1.3. PET Scan or PET-CT Scan
      • 12.2.1.4. (SPECT) Scan
    • 12.2.2. Tissue Sampling/Biopsy
    • 12.2.3. Molecular Diagnostics
    • 12.2.4. Others
  • 12.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 12.3.1. Gliomas
    • 12.3.2. Meningiomas
    • 12.3.3. Pituitary Tumors
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2023-2031
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostic Laboratories
    • 12.4.3. Cancer Hospitals/Centers
  • 12.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Diagnostic Technique
    • 12.6.2. By Brain Cancer Type
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Brain Cancer Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 13.2.1. Imaging Techniques
      • 13.2.1.1. Magnetic Resonance Imaging (MRI)
      • 13.2.1.2. Computed Tomography (CT) Scan
      • 13.2.1.3. PET Scan or PET-CT Scan
      • 13.2.1.4. (SPECT) Scan
    • 13.2.2. Tissue Sampling/Biopsy
    • 13.2.3. Molecular Diagnostics
    • 13.2.4. Others
  • 13.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 13.3.1. Gliomas
    • 13.3.2. Meningiomas
    • 13.3.3. Pituitary Tumors
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2023-2031
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostic Laboratories
    • 13.4.3. Cancer Hospitals/Centers
  • 13.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Diagnostic Technique
    • 13.6.2. By Brain Cancer Type
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Brain Cancer Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Diagnostic Technique, 2023-2031
    • 14.2.1. Imaging Techniques
      • 14.2.1.1. Magnetic Resonance Imaging (MRI)
      • 14.2.1.2. Computed Tomography (CT) Scan
      • 14.2.1.3. PET Scan or PET-CT Scan
      • 14.2.1.4. (SPECT) Scan
    • 14.2.2. Tissue Sampling/Biopsy
    • 14.2.3. Molecular Diagnostics
    • 14.2.4. Others
  • 14.3. Market Value Forecast, by Brain Cancer Type, 2023-2031
    • 14.3.1. Gliomas
    • 14.3.2. Meningiomas
    • 14.3.3. Pituitary Tumors
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2023-2031
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostic Laboratories
    • 14.4.3. Cancer Hospitals/Centers
  • 14.5. Market Value Forecast, by Country/Sub-region, 2023-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Diagnostic Technique
    • 14.6.2. By Brain Cancer Type
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2021)
  • 15.3. Company Profiles
    • 15.3.1. GE Healthcare
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Strategic Overview
      • 15.3.1.5. SWOT Analysis
    • 15.3.2. Siemens Healthineers
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Strategic Overview
      • 15.3.2.5. SWOT Analysis
    • 15.3.3. Philips Healthcare
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Strategic Overview
      • 15.3.3.5. SWOT Analysis
    • 15.3.4. Thermo Fisher Scientific
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Strategic Overview
      • 15.3.4.5. SWOT Analysis
    • 15.3.5. Roche Diagnostics
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Strategic Overview
      • 15.3.5.5. SWOT Analysis
    • 15.3.6. Abbott Laboratories
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Strategic Overview
      • 15.3.6.5. SWOT Analysis
    • 15.3.7. Illumina, Inc.
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Strategic Overview
      • 15.3.7.5. SWOT Analysis
    • 15.3.8. Hologic, Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Strategic Overview
      • 15.3.8.5. SWOT Analysis
    • 15.3.9. Agilent Technologies
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Strategic Overview
      • 15.3.9.5. SWOT Analysis
    • 15.3.10. Bio-Rad Laboratories
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Strategic Overview
      • 15.3.10.5. SWOT Analysis